The Food and Drug Administration (FDA) inspected Cardinal Health 414, LLC in Birmingham on March 16 to evaluate drug quality assurance, based on information available on the FDA’s website.
The inspection’s final report stated that Cardinal Health 414, LLC did not need to make any changes to its management practices.
Across the country, the FDA routinely inspects facilities for compliance with agency regulations and laws designed to safeguard public health. The results of these inspections are made public.
The FDA’s website describes the agency as responsible for regulating the safety and quality of human and animal pharmaceuticals, biological products, medical devices, and tobacco goods.
Information for this report was sourced from the U.S. Food and Drug Administration. The original data is available here.
